Hydrogenology
Hydrogenology editorial study record

Efficiency and safety of the integrated use of medical gases thermal heliox, nitric oxide and molecular hydrogen in patients with exacerbation of chronic obstructive pulmonary disease complicated by hypoxemic, hypercapnic respiratory failure and secondary pulmonary arterial hypertension in the post-COVID period

Shogenova LV. · Ter Arkh. 2025;97(3):242–249.

HumanInhaled H₂Published 2025
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Human

Reported design

Randomized comparative multi-arm study

Research topic

Respiratory health

Administration classification

Inhaled H₂

Study result signal

Indeterminate for molecular hydrogen.

Outcome type

Clinical, functional and laboratory outcomes for complex co-interventions.

Reported in the source

Methods at a glance

Population or model

Patients with severe COPD after COVID-19.

Sample

100 participants in five intervention groups.

Duration

14 days.

Intervention

Stabilized H₂ inhalation used in selected arms alongside thermal heliox and/or nitric oxide.

Hydrogen form

Inhaled H₂-containing gas within complex gas-treatment combinations.

H₂ specification

Ninety-minute daily H₂ sessions; concentration and flow were not reported in the article.

H₂ flow

Not reported.

O₂ delivered with H₂

Other gas interventions were separate or combined according to arm.

Comparator

Multiple gas-combination arms and a control group.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Symptoms, respiratory function, exercise tolerance and laboratory measures.

Reported result

The article reports differences across several multi-gas arms, but the design does not isolate a standalone H₂ effect.

Results-extraction completeness

The full article methods, intervention, outcomes, positive and null findings, funding and conflict statements were checked.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Complex co-interventions, limited intervention specification and single-author report prevent attribution to H₂.

Applies directly to

The specific post-COVID COPD rehabilitation protocols only.

Preliminary appraisal framework

Cochrane RoB 2 — preliminary

Preliminary risk-of-bias status

High risk

Appraisal rationale

Randomization details, concealment, blinding and arm-specific co-intervention balance were insufficiently established.

Appraisal domains

Random sequence reported or described · Allocation concealment not fully established · Deviations and co-interventions checked · Outcome measurement checked by endpoint · No outcome-level protocol comparison completed

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 40327618 · DOI: 10.26442/00403660.2025.03.203131

Publisher access

A free publisher or repository full article was checked.

Extraction basis

Publisher or repository full article and bibliographic record; checked 10 August 2026.

Record revision

2026-08-10